Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		Submit


Tuberculosis (TB)





Reported Tuberculosis in the United States, 2019						Print
																Related Pages
										Return to Main Menu
Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH)1, Origin of Birth, and Previous History of TB: United States, 1993–2019
See Surveillance Slide #41
Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: United States, 1993–2019
Year
All INH-Resistant2
Isoniazid Resistant TB CasesTotal INH-Resistant3
U.S.-Born INH-Resistant3
Non-U.S.–Born3,4 INH-ResistantPrevious TB
No previous TB
Previous TB
No previous TB
Previous TB
No previous TBEligible
No.
(%)
Eligible
No.
(%)
Eligible
No.
(%)
Eligible
No.
(%)
Eligible
No.
(%)
Eligible
No.
(%)1993
1,534
982
161
(16.4)
16,603
1,367
(8.2)
668
83
(12.4)
11,808
789
(6.7)
301
75
(24.9)
4,667
564
(12.1)1994
1,543
1033
175
(16.9)
16,418
1,352
(8.2)
693
81
(11.7)
11,010
708
(6.4)
336
93
(27.7)
5,291
632
(11.9)1995
1,352
958
168
(17.5)
16,024
1,174
(7.3)
592
77
(13.0)
10,340
554
(5.4)
364
91
(25.0)
5,653
619
(10.9)1996
1,284
862
142
(16.5)
15,360
1,133
(7.4)
559
68
(12.2)
9,637
495
(5.1)
303
74
(24.4)
5,676
637
(11.2)1997
1,195
742
109
(14.7)
14,451
1,078
(7.5)
455
35
(7.7)
8,698
435
(5.0)
286
74
(25.9)
5,708
640
(11.2)1998
1,120
749
98
(13.1)
13,420
1,011
(7.5)
485
38
(7.8)
7,695
366
(4.8)
262
60
(22.9)
5,692
643
(11.3)1999
1,000
669
82
(12.3)
12,658
900
(7.1)
382
25
(6.5)
7,011
284
(4.1)
284
55
(19.4)
5,595
614
(11.0)2000
981
632
84
(13.3)
11,829
889
(7.5)
360
22
(6.1)
6,141
269
(4.4)
272
62
(22.8)
5,659
617
(10.9)2001
897
629
87
(13.8)
11,516
800
(6.9)
324
28
(8.6)
5,571
241
(4.3)
302
59
(19.5)
5,909
558
(9.4)2002
912
570
80
(14.0)
10,823
826
(7.6)
303
23
(7.6)
5,060
206
(4.1)
265
57
(21.5)
5,722
619
(10.8)2003
904
524
65
(12.4)
10,753
823
(7.7)
253
16
(6.3)
4,853
213
(4.4)
271
49
(18.1)
5,870
606
(10.3)2004
872
538
64
(11.9)
10,483
801
(7.6)
274
15
(5.5)
4,683
214
(4.6)
264
49
(18.6)
5,790
587
(10.1)2005
842
507
70
(13.8)
10,063
761
(7.6)
240
18
(7.5)
4,393
188
(4.3)
267
52
(19.5)
5,653
567
(10.0)2006
845
493
67
(13.6)
9,909
770
(7.8)
203
9
(4.4)
4,126
173
(4.2)
289
57
(19.7)
5,767
596
(10.3)2007
798
496
71
(14.3)
9,655
715
(7.4)
206
14
(6.8)
3,849
163
(4.2)
288
57
(19.8)
5,763
549
(9.5)2008
835
429
57
(13.3)
9,308
774
(8.3)
170
13
(7.6)
3,646
188
(5.2)
259
44
(17.0)
5,656
585
(10.3)2009
762
343
52
(15.2)
8,230
699
(8.5)
116
6
(5.2)
3,092
192
(6.2)
226
46
(20.4)
5,130
507
(9.9)2010
692
360
63
(17.5)
7,790
622
(8.0)
131
13
(9.9)
2,926
165
(5.6)
229
50
(21.8)
4,858
457
(9.4)2011
753
343
59
(17.2)
7,538
687
(9.1)
135
9
(6.7)
2,691
172
(6.4)
208
50
(24.0)
4,844
515
(10.6)2012
686
356
55
(15.4)
7,077
631
(8.9)
127
8
(6.3)
2,516
146
(5.8)
229
47
(20.5)
4,561
485
(10.6)2013
675
300
48
(16.0)
6,859
622
(9.1)
98
8
(8.2)
2,280
131
(5.7)
202
40
(19.8)
4,574
491
(10.7)2014
688
336
63
(18.8)
6,741
621
(9.2)
94
5
(5.3)
2,180
162
(7.4)
242
58
(24.0)
4,557
459
(10.1)2015
685
317
51
(16.1)
6,957
633
(9.1)
100
7
(7.0)
2,189
150
(6.9)
217
44
(20.3)
4,763
482
(10.1)2016
651
302
57
(18.9)
6,724
590
(8.8)
83
7
(8.4)
2,052
123
(6.0)
219
50
(22.8)
4,667
467
(10.0)2017
635
280
54
(19.3)
6,577
577
(8.8)
59
3
(5.1)
1,841
104
(5.6)
221
51
(23.1)
4,732
472
(10.0)2018
637
289
52
(18.0)
6,542
581
(8.9)
57
7
(12.3)
1,868
102
(5.5)
232
45
(19.4)
4,672
479
(10.3)2019
631
276
39
(14.1)
6,270
575
(9.2)
62
6
(9.7)
1,730
112
(6.5)
214
33
(15.4)
4,532
463
(10.2)1Resistance to at least isoniazid. Isolates may be resistant to other drugs. Excludes cases with susceptibility testing not done or unknown for isoniazid. Cases have been susceptibility tested to at least isoniazid and rifampin.2This column provides an overall total of all INH-resistant cases, including those where previous history of TB is unknown and origin or birth is unknown.3Excludes cases where previous history of TB is unknown and cases where origin of birth is unknown.4Includes persons born outside the United States (including the U.S. territories).
**Note:** Data for all years updated through June 10, 2020.Table Printing Tips
							
					
							Last Reviewed:  October 26, 2020						Source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisData and Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City Reports


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue